Several countries across regions and income groups have notified WHO of constraints to their access of HPV vaccines. The issue of affordability has also been raised, particularly by non-Gavi MICs. Following the announcement of a call for action towards global elimination of cervical cancer by the WHO Director General in May 2018, increasing introduction and coverage of HPV vaccine worldwide will be key. Working to understand current and future global trends and drivers of supply and demand, this study aims to address the current and expected constraints and to serve as an important resource for the development of the cervical cancer elimination strategy.
|Added on||21 March 2019 11:13:24|
Add to Favourites